Copyright Reports & Markets. All rights reserved.

Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Drug Substance Development and Manufacturing
      • 1.4.3 Specialized Services
      • 1.4.4 Lab-based Services
    • 1.5 Market by Application
      • 1.5.1 Global Pharmaceutical CDMO Services Market Share by Application (2019-2025)
      • 1.5.2 Innovative Medicine
      • 1.5.3 Patented Drug
      • 1.5.4 Patent Expired Drug
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pharmaceutical CDMO Services Market Size
    • 2.2 Pharmaceutical CDMO Services Growth Trends by Regions
      • 2.2.1 Pharmaceutical CDMO Services Market Size by Regions (2019-2025)
      • 2.2.2 Pharmaceutical CDMO Services Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Pharmaceutical CDMO Services Market Size by by Players
      • 3.1.1 Global Pharmaceutical CDMO Services Revenue by by Players (2014-2019)
      • 3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pharmaceutical CDMO Services Key Players Head office and Area Served
    • 3.3 Key Players Pharmaceutical CDMO Services Product/Solution/Service
    • 3.4 Date of Enter into Pharmaceutical CDMO Services Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pharmaceutical CDMO Services Market Size by Type (2014-2019)
    • 4.2 Global Pharmaceutical CDMO Services Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Pharmaceutical CDMO Services Market Size (2014-2019)
    • 5.2 Pharmaceutical CDMO Services Key Players in North America
    • 5.3 North America Pharmaceutical CDMO Services Market Size by Type
    • 5.4 North America Pharmaceutical CDMO Services Market Size by Application

    6 Europe

    • 6.1 Europe Pharmaceutical CDMO Services Market Size (2014-2019)
    • 6.2 Pharmaceutical CDMO Services Key Players in Europe
    • 6.3 Europe Pharmaceutical CDMO Services Market Size by Type
    • 6.4 Europe Pharmaceutical CDMO Services Market Size by Application

    7 China

    • 7.1 China Pharmaceutical CDMO Services Market Size (2014-2019)
    • 7.2 Pharmaceutical CDMO Services Key Players in China
    • 7.3 China Pharmaceutical CDMO Services Market Size by Type
    • 7.4 China Pharmaceutical CDMO Services Market Size by Application

    8 Japan

    • 8.1 Japan Pharmaceutical CDMO Services Market Size (2014-2019)
    • 8.2 Pharmaceutical CDMO Services Key Players in Japan
    • 8.3 Japan Pharmaceutical CDMO Services Market Size by Type
    • 8.4 Japan Pharmaceutical CDMO Services Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pharmaceutical CDMO Services Market Size (2014-2019)
    • 9.2 Pharmaceutical CDMO Services Key Players in Southeast Asia
    • 9.3 Southeast Asia Pharmaceutical CDMO Services Market Size by Type
    • 9.4 Southeast Asia Pharmaceutical CDMO Services Market Size by Application

    10 India

    • 10.1 India Pharmaceutical CDMO Services Market Size (2014-2019)
    • 10.2 Pharmaceutical CDMO Services Key Players in India
    • 10.3 India Pharmaceutical CDMO Services Market Size by Type
    • 10.4 India Pharmaceutical CDMO Services Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pharmaceutical CDMO Services Market Size (2014-2019)
    • 11.2 Pharmaceutical CDMO Services Key Players in Central & South America
    • 11.3 Central & South America Pharmaceutical CDMO Services Market Size by Type
    • 11.4 Central & South America Pharmaceutical CDMO Services Market Size by Application

    12 International Players Profiles

    • 12.1 Recipharm AB
      • 12.1.1 Recipharm AB Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pharmaceutical CDMO Services Introduction
      • 12.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2014-2019))
      • 12.1.5 Recipharm AB Recent Development
    • 12.2 AMRI Global
      • 12.2.1 AMRI Global Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pharmaceutical CDMO Services Introduction
      • 12.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.2.5 AMRI Global Recent Development
    • 12.3 Patheon N.V.
      • 12.3.1 Patheon N.V. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pharmaceutical CDMO Services Introduction
      • 12.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.3.5 Patheon N.V. Recent Development
    • 12.4 Aenova Group
      • 12.4.1 Aenova Group Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pharmaceutical CDMO Services Introduction
      • 12.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.4.5 Aenova Group Recent Development
    • 12.5 Catalent, Inc.
      • 12.5.1 Catalent, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pharmaceutical CDMO Services Introduction
      • 12.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.5.5 Catalent, Inc. Recent Development
    • 12.6 Amatsigroup
      • 12.6.1 Amatsigroup Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pharmaceutical CDMO Services Introduction
      • 12.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.6.5 Amatsigroup Recent Development
    • 12.7 WuXi AppTec Group
      • 12.7.1 WuXi AppTec Group Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pharmaceutical CDMO Services Introduction
      • 12.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.7.5 WuXi AppTec Group Recent Development
    • 12.8 Strides Pharma Science Limited
      • 12.8.1 Strides Pharma Science Limited Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pharmaceutical CDMO Services Introduction
      • 12.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.8.5 Strides Pharma Science Limited Recent Development
    • 12.9 Piramal Pharma Solutions
      • 12.9.1 Piramal Pharma Solutions Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pharmaceutical CDMO Services Introduction
      • 12.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.9.5 Piramal Pharma Solutions Recent Development
    • 12.10 Siegfried Ltd
      • 12.10.1 Siegfried Ltd Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Pharmaceutical CDMO Services Introduction
      • 12.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2014-2019)
      • 12.10.5 Siegfried Ltd Recent Development
    • 12.11 Fareva Group
    • 12.12 FAMAR Health Care Services

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
      In 2018, the global Pharmaceutical CDMO Services market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pharmaceutical CDMO Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical CDMO Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Recipharm AB
      AMRI Global
      Patheon N.V.
      Aenova Group
      Catalent, Inc.
      Amatsigroup
      WuXi AppTec Group
      Strides Pharma Science Limited
      Piramal Pharma Solutions
      Siegfried Ltd
      Fareva Group
      FAMAR Health Care Services

      Market segment by Type, the product can be split into
      Drug Substance Development and Manufacturing
      Specialized Services
      Lab-based Services

      Market segment by Application, split into
      Innovative Medicine
      Patented Drug
      Patent Expired Drug

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pharmaceutical CDMO Services status, future forecast, growth opportunity, key market and key players.
      To present the Pharmaceutical CDMO Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pharmaceutical CDMO Services are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now